Related Experiment Video
Updated: Apr 4, 2026

Home-Based Prescribed Pulmonary Exercise in Patients with Stable Chronic Obstructive Pulmonary Disease
Published on: August 24, 2019
A Personalized, Home-Based, Multidisciplinary Outpatient Clinic for Managing Breathlessness in Chronic Obstructive
Jonathan Shung-Yi Lee1, Belinda Cochrane1,2, Tracy A Smith3,4
1Department of Respiratory Medicine, Camden and Campbelltown Hospitals, Sydney, Australia.
Background:
Breathlessness is a distressing symptom for people with chronic obstructive pulmonary disease (COPD), impacting independence and community participation, resulting in reduced quality of life. With optimized treatment, nonpharmaceutical interventions deployed in a home-based breathlessness intervention service may reduce breathlessness to a manageable level.
Objective:
The aim of this study is to investigate whether patients with COPD experience reduced burden of chronic breathlessness and health care use following participation in the Macarthur Breathless Clinic (MBC), a multidisciplinary home-based health service intervention and to explore participant and carer experiences.
Methods:
The proposed research is a single-site, mixed methods, single-arm cohort study evaluating MBC. Eligible participants will have chronic breathlessness as defined by a modified Medical Research Council score of at least 2 and COPD confirmed by spirometry. Initially, participants will undergo a holistic medical assessment to understand factors contributing to breathlessness and to optimize therapy. The MBC intervention will be a 9-week, home-based, multidisciplinary program (with contributions from medical, nursing, physiotherapy, and occupational therapy clinicians). Central to this program will be coaching for breathlessness self-management using individualized, multicomponent strategies. Breathlessness impact will be assessed using questionnaire instruments measuring breathlessness mastery, symptom burden, quality of life, and psychological distress, with the Chronic Respiratory Questionnaire's mastery subscale as primary outcome. Assessments will be undertaken at baseline, 9 weeks, and 52 weeks; 12-month exacerbation rates, health care use, and rescue medication use will be monitored and measured against participants' historical data. Participant and carer experiences will be evaluated using qualitative methods to inform development of the service.
Results:
This project was funded in stages according to defined milestones, with the final milestone payment received in October 2025. Data collection commenced in March 2022. On submission of this manuscript, recruitment is complete with 92 participants having completed the protocol by March 2024. Data analysis is ongoing, and results are expected to be reported by early 2027.
Conclusions:
This research protocol is the first to investigate long-term outcomes following a health service intervention targeting chronic breathlessness for patients with COPD. Positive results may see breathlessness strategies from MBC or other similar health service interventions incorporated into existing models of chronic COPD care.
Trial Registration:
Australian and New Zealand Clinical Trial Registry ACTRN12620001330932; https://tinyurl.com/35fec8h4.
International Registered Report Identifier (Irrid):
DERR1-10.2196/85766.
More Related Videos
04:24Acupoint Application as a Traditional Chinese Medicine Treatment for Fatigue Associated with Chronic Obstructive Pulmonary Disease
Published on: September 5, 2025
09:42Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
Related Concept Videos
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...